FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Richard Rubin

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Richard R Rubin; Monika Safford; Thomas A Wadden; Don Williamson; Rena R Wing; Mark A Espeland; Gina Evans-Hudnall; Linda Ewing; Lucy F Faulconbridge; Sarah A Gaussoin; William C Knowler; Mark Peyrot
Four-Year Analysis of Cardiovascular Disease Risk Factors, Depression Symptoms, and Antidepressant Medicine Use in the Look AHEAD (Action for Health in Diabetes) Clinical Trial of Weight Loss in Diabetes.
Craig J Currie; Christopher M Burton; Sara Jenkins-Jones; Christopher Ll Morgan; Mark Peyrot; Chris D Poole; Richard R Rubin; Marc Evans
The impact of treatment non-compliance on mortality in people with type 1 diabetes.
Mark Peyrot; Richard R Rubin
Treatment satisfaction in the sensor-augmented pump therapy for A1C reduction 3 (STAR 3) trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Richard Rubin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Richard R Rubin; Monika Safford; Thomas A Wadden; Don Williamson; Rena R Wing; Mark A Espeland; Gina Evans-Hudnall; Linda Ewing; Lucy F Faulconbridge; Sarah A Gaussoin; William C Knowler; Mark Peyrot
Four-Year Analysis of Cardiovascular Disease Risk Factors, Depression Symptoms, and Antidepressant Medicine Use in the Look AHEAD (Action for Health in Diabetes) Clinical Trial of Weight Loss in Diabetes.
Diabetes care 2013;36(5):1088-94.
2013: Craig J Currie; Christopher M Burton; Sara Jenkins-Jones; Christopher Ll Morgan; Mark Peyrot; Chris D Poole; Richard R Rubin; Marc Evans
The impact of treatment non-compliance on mortality in people with type 1 diabetes.
Journal of diabetes and its complications 2013;27(3):219-23.
2013: Mark Peyrot; Richard R Rubin
Treatment satisfaction in the sensor-augmented pump therapy for A1C reduction 3 (STAR 3) trial.
Diabetic medicine : a journal of the British Diabetic Association 2013;30(4):464-7.
2013: David W Price; Richard R Rubin; Elizabeth Barrett-Connor; George A Bray; William C Knowler; D Yvette LaCoursiere; Yong Ma; David Marrero; Leigh Perreault
Depression as a predictor of weight regain among successful weight losers in the diabetes prevention program.
Diabetes care 2013;36(2):216-21.
2012: Hermes Florez; Ronald B Goldberg; Andrea Kriska; David G Marrero; Qing Pan; Richard R Rubin; Christopher D Saudek; Ronald T Ackermann; Elizabeth Barrett-Connor; Linda Delahanty
Impact of lifestyle intervention and metformin on health-related quality of life: the diabetes prevention program randomized trial.
Journal of general internal medicine 2012;27(12):1594-601.
2012: Mark Peyrot; A C Shillington; Y Xu; Q Harshaw; Richard R Rubin
Validation of a tool to assess medication treatment satisfaction in patients with Type 2 diabetes: the Diabetes Medication System Rating Questionnaire (DMSRQ).
Diabetic medicine : a journal of the British Diabetic Association 2012;29(8):1060-6.
2012: Craig J Currie; Christopher M Burton; Sara Jenkins-Jones; Christopher Ll Morgan; Mark Peyrot; Chris D Poole; Richard R Rubin; Marc Evans
The impact of treatment noncompliance on mortality in people with type 2 diabetes.
Diabetes care 2012;35(6):1279-84.
2012: An Pan; Richard R Rubin; Qi Sun; Nana Keum; Mika Kivimaki; Olivia I Okereke; Frank B Hu
Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies.
Diabetes care 2012;35(5):1171-80.
2012: Lucy F Faulconbridge; David L Mount; Richard R Rubin; Brent Van Dorsten; Thomas A Wadden; Michael P Walkup; Rena R Wing; Mace Coday; Linda J Ewing; Anthony N Fabricatore
One-year changes in symptoms of depression and weight in overweight/obese individuals with type 2 diabetes in the Look AHEAD study.
Obesity (Silver Spring, Md.) 2012;20(4):783-93.
2012: Richard R Rubin; Mark Peyrot
Health-related quality of life and treatment satisfaction in the Sensor-Augmented Pump Therapy for A1C Reduction 3 (STAR 3) trial.
Diabetes technology & therapeutics 2012;14(2):143-51.
2012: A Pan; Kathryn M Rexrode; Richard R Rubin; Q Sun; W C Willett; M Lucas; J E Manson; Olivia I Okereke; Frank B Hu
Use of antidepressant medication and risk of type 2 diabetes: results from three cohorts of US adults.
Diabetologia 2012;55(1):63-72.
2011: Mark Peyrot; Richard R Rubin
Patient-reported outcomes in adults with type 2 diabetes using mealtime inhaled technosphere insulin and basal insulin versus premixed insulin.
Diabetes technology & therapeutics 2011;13(12):1201-6.
2011: Lawrence J Appel; Jeanne Charleston; Jeanne M Clark; Janelle W Coughlin; Arlene Dalcin; Gail L Daumit; Nowella Durkin; Steven Geller; Gerald J. Jerome; Thomas A Louis; Edgar R Miller; Gary Noronha; Thomas Pozefsky; Jeffrey B Reynolds; Richard R Rubin; Nae-Yuh Wang; Hsin-Chieh Yeh; frederick brancati
Comparative effectiveness of weight-loss interventions in clinical practice.
The New England journal of medicine 2011;365(21):1959-68.
2011: Richard R Rubin; Yaping Xu; Barbara Lippe; Leah McCormack; Catherine P Metzinger; Mark Peyrot; Daniel Aaron Davis
An observational study to validate the Satisfaction Measure of the Injection of Growth Hormone Therapy (SMIGHTy) questionnaire.
Current medical research and opinion 2011;27(10):2009-17.
2011: Mark Peyrot; Richard R Rubin; Xiaojing Chen; Juan P Frias
Associations between improved glucose control and patient-reported outcomes after initiation of insulin pump therapy in patients with type 2 diabetes mellitus.
Diabetes technology & therapeutics 2011;13(4):471-6.
2011: Jennie H Best; Richard R Rubin; Mark Peyrot; Yan Li; Ping Yan; Jaret Malloy; Louis P Garrison
Weight-related quality of life, health utility, psychological well-being, and satisfaction with exenatide once weekly compared with sitagliptin or pioglitazone after 26 weeks of treatment.
Diabetes care 2011;34(2):314-9.
2011: Richard R Rubin; Mark Peyrot
Factors associated with physician perceptions of and willingness to recommend inhaled insulin.
Current medical research and opinion 2011;27(2):285-94.
2011: Mark Peyrot; Richard R Rubin
Perceived medication benefits and their association with interest in using inhaled insulin in type 2 diabetes: a model of patients' cognitive framework.
Patient preference and adherence 2011;5():255-65.
2011: Richard R Rubin; Sarah K Borgman; Becky T Sulik
Crossing the technology divide: practical strategies for transitioning patients from multiple daily insulin injections to sensor-augmented pump therapy.
The Diabetes educator 2011;37 Suppl 1():5S-18S; quiz 19S-20S.
2011: Mark Peyrot; Richard R Rubin
Factors associated with persistence and resumption of insulin pen use for patients with type 2 diabetes.
Diabetes technology & therapeutics 2011;13(1):43-8.
2010: Sheri R Colberg; Ronald J Sigal; Bo Fernhall; Judith G Regensteiner; Bryan J Blissmer; Richard R Rubin; Lisa Chasan-Taber; Ann L Albright; Barry Braun
Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary.
Diabetes care 2010;33(12):2692-6.
2010: Sheri R Colberg; Ronald J Sigal; Bo Fernhall; Judith G Regensteiner; Bryan J Blissmer; Richard R Rubin; Lisa Chasan-Taber; Ann L Albright; Barry Braun
Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement.
Diabetes care 2010;33(12):e147-67.
2010: Sheri R Colberg; Bo Fernhall; Judith G Regensteiner; Richard R Rubin; Ronald J Sigal; Ann L Albright; Bryan J Blissmer; Barry Braun; Lisa Chasan-Taber
Exercise and type 2 diabetes: American College of Sports Medicine and the American Diabetes Association: joint position statement. Exercise and type 2 diabetes.
Medicine and science in sports and exercise 2010;42(12):2282-303.
2010: Richard R Rubin; Yong Ma; Mark Peyrot; David G Marrero; David W Price; Elizabeth Barrett-Connor; William C Knowler
Antidepressant medicine use and risk of developing diabetes during the diabetes prevention program and diabetes prevention program outcomes study.
Diabetes care 2010;33(12):2549-51.
2010: Richard R Rubin; Mark Peyrot; Xiaojing Chen; Juan P Frias
Patient-reported outcomes from a 16-week open-label, multicenter study of insulin pump therapy in patients with type 2 diabetes mellitus.
Diabetes technology & therapeutics 2010;12(11):901-6.
2010: Jeffrey Gonzalez; L Vileikyte; J S Ulbrecht; Richard R Rubin; A P Garrow; C Delgado; P R Cavanagh; A J M Boulton; Mark Peyrot
Depression predicts first but not recurrent diabetic foot ulcers.
Diabetologia 2010;53(10):2241-8.
2010: Richard R Rubin; Mark Peyrot
Patient-reported outcomes and diabetes technology: a systematic review of the literature.
Pediatric endocrinology reviews : PER 2010;7 Suppl 3():405-12.
2010: Richard R Rubin; S A Gaussoin; Mark Peyrot; V DiLillo; Kathy D Miller; T A Wadden; D S West; R R Wing; William C Knowler
Cardiovascular disease risk factors, depression symptoms and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes.
Diabetologia 2010;53(8):1581-9.
2010: Gali Shapira; Ofer Yodfat; Arava HaCohen; Paul Feigin; Richard R Rubin
Bolus guide: a novel insulin bolus dosing decision support tool based on selection of carbohydrate ranges.
Journal of diabetes science and technology 2010;4(4):893-902.
2010: Mark Peyrot; Richard R Rubin; William H Polonsky; Jennie H Best
Patient reported outcomes in adults with type 2 diabetes on basal insulin randomized to addition of mealtime pramlintide or rapid-acting insulin analogs.
Current medical research and opinion 2010;26(5):1047-54.
2010: Mark Peyrot; Richard R Rubin; Kamlesh Khunti
Addressing barriers to initiation of insulin in patients with type 2 diabetes.
Primary care diabetes 2010;4 Suppl 1():S11-8.
2010: Stephen N Davis; Edward S Horton; Tadej Battelino; Richard R Rubin; Kevin Schulman; William V Tamborlane
STAR 3 randomized controlled trial to compare sensor-augmented insulin pump therapy with multiple daily injections in the treatment of type 1 diabetes: research design, methods, and baseline characteristics of enrolled subjects.
Diabetes technology & therapeutics 2010;12(4):249-55.
2010: Mark Peyrot; Richard R Rubin; Davida F Kruger; Luther B Travis
Correlates of insulin injection omission.
Diabetes care 2010;33(2):240-5.
2010: Richard R Rubin; Mark Peyrot
Psychometric properties of an instrument for assessing the experience of patients treated with inhaled insulin: the inhaled insulin treatment questionnaire (IITQ).
Health and quality of life outcomes 2010;8():32.
2010: Mark Peyrot; Richard R Rubin
Effect of technosphere inhaled insulin on quality of life and treatment satisfaction.
Diabetes technology & therapeutics 2010;12(1):49-55.
2009: Richard R Rubin; Mark Peyrot
Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump.
Journal of diabetes science and technology 2009;3(6):1402-10.
2009: Richard R Rubin; Mark Peyrot; Davida F Kruger; Luther B Travis
Barriers to insulin injection therapy: patient and health care provider perspectives.
The Diabetes educator 2009;35(6):1014-22.
2009: Mark Peyrot; Richard R Rubin
How does treatment satisfaction work?: Modeling determinants of treatment satisfaction and preference.
Diabetes care 2009;32(8):1411-7.
2009: J H Best; K S Boye; Richard R Rubin; D Cao; T H Kim; Mark Peyrot
Improved treatment satisfaction and weight-related quality of life with exenatide once weekly or twice daily.
Diabetic medicine : a journal of the British Diabetic Association 2009;26(7):722-8.
2009: Loretta Vileikyte; Mark Peyrot; Jeffrey Gonzalez; Richard R Rubin; Adam P Garrow; D Stickings; Christine Waterman; Jan S Ulbrecht; Peter R. Cavanagh; A J M Boulton
Predictors of depressive symptoms in persons with diabetic peripheral neuropathy: a longitudinal study.
Diabetologia 2009;52(7):1265-73.
2009: Loretta Vileikyte; Richard R Rubin; Mark Peyrot; Jeffrey Gonzalez; Andrew J M Boulton; Jan S Ulbrecht; Peter R. Cavanagh
Diabetic feet.
The British journal of general practice : the journal of the Royal College of General Practitioners 2009;59(561):290.
2009: Mark Peyrot; Richard R Rubin; Martha M Funnell; Linda M Siminerio
Access to diabetes self-management education: results of national surveys of patients, educators, and physicians.
The Diabetes educator 2009;35(2):246-8, 252-6, 258-63.
2009: Richard R Rubin; Mark Peyrot
Psychometric properties of an instrument for assessing treatment satisfaction associated with pramlintide use.
The Diabetes educator 2009;35(1):136-46.
2009: Mark Peyrot; Richard R Rubin
Patient-reported outcomes for an integrated real-time continuous glucose monitoring/insulin pump system.
Diabetes technology & therapeutics 2009;11(1):57-62.
2008: Mark Peyrot; Richard R Rubin; William H Polonsky
Diabetes distress and its association with clinical outcomes in patients with type 2 diabetes treated with pramlintide as an adjunct to insulin therapy.
Diabetes technology & therapeutics 2008;10(6):461-6.
2008: David Klonoff; Richard Bergenstal; Lawrence Blonde; Suzanne Austin Boren; Timothy S Church; Jenifer Gaffaney; Lois Jovanovic; David M Kendall; Craig Kollman; Boris Kovatchev; Claudia Leippert; David R Owens; William H Polonsky; Gérard Reach; Eric Renard; Michael C Riddell; Richard R Rubin; Oliver Schnell; Linda M Siminiero; Robert Vigersky; Darrell M Wilson; Alison Okada Wollitzer
Consensus report of the coalition for clinical research-self-monitoring of blood glucose.
Journal of diabetes science and technology 2008;2(6):1030-53.
2008: Mark Peyrot; Richard R Rubin
Physician perception and recommendation of insulin pens for patients with type 2 diabetes mellitus.
Current medical research and opinion 2008;24(8):2413-22.
2008: Richard R Rubin; Yong Ma; David G Marrero; Mark Peyrot; Elizabeth L Barrett-Connor; Steven E Kahn; Steven M Haffner; David W Price; William C Knowler
Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program.
Diabetes care 2008;31(3):420-6.
2008: Richard R Rubin; Mark Peyrot
Factors affecting use of insulin pens by patients with type 2 diabetes.
Diabetes care 2008;31(3):430-2.
2008: Mark Peyrot; Richard R Rubin
Access to diabetes self-management education.
The Diabetes educator 2008;34(1):90-7.
2007: Mark Peyrot; Richard R Rubin
Behavioral and psychosocial interventions in diabetes: a conceptual review.
Diabetes care 2007;30(10):2433-40.
2007: Richard R Rubin; Mark Peyrot
Assessing treatment satisfaction in patients treated with pramlintide as an adjunct to insulin therapy.
Current medical research and opinion 2007;23(8):1919-29.
2007: David G Marrero; John Crean; Bei Zhang; Terrie Kellmeyer; Maurice Gloster; Kathrin Herrmann; Richard R Rubin; Naomi S Fineberg; Orville G Kolterman
Effect of adjunctive pramlintide treatment on treatment satisfaction in patients with type 1 diabetes.
Diabetes care 2007;30(2):210-6.
2007: Linda M Siminerio; Martha M Funnell; Mark Peyrot; Richard R Rubin
US nurses' perceptions of their role in diabetes care: results of the cross-national Diabetes Attitudes Wishes and Needs (DAWN) study.
The Diabetes educator 2007;33(1):152-62.
2006: Loretta Vileikyte; Jeffrey Gonzalez; Howard Leventhal; Mark Peyrot; Richard R Rubin; Adam P Garrow; Jan S Ulbrecht; Peter R. Cavanagh; Andrew J M Boulton
Patient Interpretation of Neuropathy (PIN) questionnaire: an instrument for assessment of cognitive and emotional factors associated with foot self-care.
Diabetes care 2006;29(12):2617-24.
2006: Mark Peyrot; Richard R Rubin; Linda M Siminerio
Physician and nurse use of psychosocial strategies in diabetes care: results of the cross-national Diabetes Attitudes, Wishes and Needs (DAWN) study.
Diabetes care 2006;29(6):1256-62.
2006: Richard R Rubin; Mark Peyrot; Linda M Siminerio
Health care and patient-reported outcomes: results of the cross-national Diabetes Attitudes, Wishes and Needs (DAWN) study.
Diabetes care 2006;29(6):1249-55.
2006: W Jack Rejeski; Wei Lang; Rebecca H Neiberg; Brent Van Dorsten; Gary D Foster; Matthew Maciejewski; Richard R Rubin; David F Williamson
Correlates of health-related quality of life in overweight and obese adults with type 2 diabetes.
Obesity (Silver Spring, Md.) 2006;14(5):870-83.
2006: Mark Peyrot; Richard R Rubin; Torsten Lauritzen; Soren E Skovlund; Frank J Snoek; David R Matthews; R Landgraf
Patient and provider perceptions of care for diabetes: results of the cross-national DAWN Study.
Diabetologia 2006;49(2):279-88.
2005: Mark Peyrot; Richard R Rubin; Torsten Lauritzen; Soren E Skovlund; Frank J Snoek; David R Matthews; Rüdiger Landgraf; Line Kleinebreil
Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study.
Diabetes care 2005;28(11):2673-9.
2005: Loretta Vileikyte; Howard Leventhal; Jeffrey Gonzalez; Mark Peyrot; Richard R Rubin; Jan S Ulbrecht; Adam P Garrow; Christine Waterman; Peter R. Cavanagh; Andrew J M Boulton
Diabetic peripheral neuropathy and depressive symptoms: the association revisited.
Diabetes care 2005;28(10):2378-83.
2005: Mark Peyrot; Richard R Rubin; Torsten Lauritzen; Frank J Snoek; David R Matthews; Soren E Skovlund
Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study.
Diabetic medicine : a journal of the British Diabetic Association 2005;22(10):1379-85.
2005: Stephen Brunton; Blaine Carmichael; Martha M Funnell; Daniel Lorber; Robert Rakel; Richard R Rubin
Type 2 diabetes: the role of insulin.
The Journal of family practice 2005;54(5):445-52.
2005: Richard R Rubin
Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus.
The American journal of medicine 2005;118 Suppl 5A():27S-34S.
2005: Richard R Rubin; William C Knowler; Yong Ma; David G Marrero; Sharon L Edelstein; Elizabeth A Walker; Sanford A Garfield; Edwin Bailey Fisher
Depression symptoms and antidepressant medicine use in Diabetes Prevention Program participants.
Diabetes care 2005;28(4):830-7.
2005: Mark Peyrot; Richard R Rubin
Validity and reliability of an instrument for assessing health-related quality of life and treatment preferences: the Insulin Delivery System Rating Questionnaire.
Diabetes care 2005;28(1):53-8.
2004: Richard R Rubin; Mark Peyrot
Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies.
Diabetes care 2004;27(10):2495-7.
2004: Loretta Vileikyte; Richard R Rubin; Howard Leventhal
Psychological aspects of diabetic neuropathic foot complications: an overview.
Diabetes/metabolism research and reviews 2004;20 Suppl 1():S13-8.
2004: Richard R Rubin; Paul Ciechanowski; Leonard E Egede; Elizabeth H B Lin; Patrick J Lustman
Recognizing and treating depression in patients with diabetes.
Current diabetes reports 2004;4(2):119-25.
2003: Loretta Vileikyte; Mark Peyrot; Christine Bundy; Richard R Rubin; Howard Leventhal; Pablo A Mora; Jonathan E Shaw; Paul Baker; Andrew J M Boulton
The development and validation of a neuropathy- and foot ulcer-specific quality of life instrument.
Diabetes care 2003;26(9):2549-55.
2002: Richard R Rubin; Mark Peyrot
Was Willis right? Thoughts on the interaction of depression and diabetes.
Diabetes/metabolism research and reviews 2002;18(3):173-5.
2002: Richard R Rubin; Wilfred Y Fujimoto; David G Marrero; Tina Brenneman; Jeanne Charleston; Sharon L Edelstein; Edwin Bailey Fisher; Ruth Jordan; William C Knowler; Lynne C Lichterman; Melvin Prince; Patricia M Rowe
The Diabetes Prevention Program: recruitment methods and results.
Controlled clinical trials 2002;23(2):157-71.
2001: Alan M Delamater; A M Jacobson; B Anderson; D Cox; L Fisher; P Lustman; Richard R Rubin; T Wysocki
Psychosocial therapies in diabetes: report of the Psychosocial Therapies Working Group.
Diabetes care 2001;24(7):1286-92.
2001: L I Aljasem; Mark Peyrot; Lawrence S Wissow; Richard R Rubin
The impact of barriers and self-efficacy on self-care behaviors in type 2 diabetes.
The Diabetes educator 2001;27(3):393-404.
2001: Richard R Rubin; Mark Peyrot
Psychological issues and treatments for people with diabetes.
Journal of clinical psychology 2001;57(4):457-78.
2000: M R Graff; Richard R Rubin; Elizabeth A Walker
How diabetes specialists treat their own diabetes: findings from a study of the AADE and ADA membership.
The Diabetes educator 2000;26(3):460-7.
1999: Richard R Rubin; Mark Peyrot
Quality of life and diabetes.
Diabetes/metabolism research and reviews 1999;15(3):205-18.
1999: R E Glasgow; Edwin Bailey Fisher; B J Anderson; Annette M. LaGreca; David G Marrero; S B Johnson; Richard R Rubin; D J Cox
Behavioral science in diabetes. Contributions and opportunities.
Diabetes care 1999;22(5):832-43.
1999: Mark Peyrot; Richard R Rubin
Persistence of depressive symptoms in diabetic adults.
Diabetes care 1999;22(3):448-52.
1997: Mark Peyrot; Richard R Rubin
Levels and risks of depression and anxiety symptomatology among diabetic adults.
Diabetes care 1997;20(4):585-90.
1994: Mark Peyrot; Richard R Rubin
Structure and correlates of diabetes-specific locus of control.
Diabetes care 1994;17(9):994-1001.
1994: Richard R Rubin; Mark Peyrot
Implications of the DCCT. Looking beyond tight control.
Diabetes care 1994;17(3):235-6.
1994: Mark Peyrot; Richard R Rubin
Modeling the effect of diabetes education on glycemic control.
The Diabetes educator 1994;20(2):143-8.
1992: Richard R Rubin; Mark Peyrot
Psychosocial problems and interventions in diabetes. A review of the literature.
Diabetes care 1992;15(11):1640-57.
1991: Richard R Rubin; Mark Peyrot; Christopher D Saudek
Differential effect of diabetes education on self-regulation and life-style behaviors.
Diabetes care 1991;14(4):335-8.
1989: Richard R Rubin; Mark Peyrot; Christopher D Saudek
Effect of diabetes education on self-care, metabolic control, and emotional well-being.
Diabetes care 1989;12(10):673-9.
1975: Richard R Rubin; JOEL ELKES; R W Maris; P E Dietz
Medicine and the behavioral sciences: the Johns Hopkins M. D. - Ph. D. program.
The Johns Hopkins medical journal 1975;136(6):268-70.